Shield Bio
ClosedBringing 3rd generation, nanopore sequencing to healthcare to solve…
- Headquarters
- San Jose, California
- Employees
- 11–50
- Website
- shieldbio.com
- Last Round
- SeedJun 2016
- Rounds
- 1
About
Shield Bio is a precision medicine company with a proprietary platform that enables reliable nanopore sequencing in under a minute, in a clinical setting. It is focused on bringing 3rd generation or "nanopore" sequencing into clinical use to deliver on the promise of precision medicine. Shield is initially using the technology to improve the treatment of infectious disease and address the unmet clinical need of sepsis, which kills 300,000 people a year in the US alone.
Summary
Shield Bio is a Genomics company based in San Jose, United States. Its most recent funding was a Seed round in Jun 2016. Investors include Y Combinator.
Funding History
Jun 2016
Investors
Similar Companies
Biotechnology company developing multi-cancer early detection blood tests using high-intensity ge...
Provides comprehensive molecular profiling and AI-driven precision oncology services for physicia...
Provides genomic profiling tests and data services to oncologists and biopharma partners to guide...
Ultima Genomics develops high-throughput DNA sequencing platforms that use open-wafer technology ...
Biopharmaceutical company developing and commercializing RNAi therapeutics to treat genetically d...
Largest private manufacturer and distributor of medical-surgical products serving healthcare prov...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/shield-bio"><img src="https://indexed.vc/api/badge/company/shield-bio" alt="Shield Bio on Indexed.vc" width="260" height="76" /></a>